China Resources Pharmaceutical Group Limited (HKG:3320)

HKG:3320 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	15,622	15,844	16,425	24,651	15,224	14,267
Short-Term Investments	-	11,966	9,223	7,581	7,507	9,766
Trading Asset Securities	-	103.14	-	-	-	-
Cash & Short-Term Investments	15,622	27,913	25,648	32,231	22,731	24,034
Cash Growth	-50.44%	8.83%	-20.43%	41.79%	-5.42%	57.29%
Accounts Receivable	112,014	106,421	101,670	95,695	84,818	78,175
Other Receivables	1,088	8,413	8,657	6,912	6,845	7,612
Receivables	113,102	114,834	110,327	102,607	91,663	85,787
Inventory	45,073	43,271	37,053	31,875	26,547	24,186
Prepaid Expenses	-	4,016	4,076	4,797	4,953	3,506
Restricted Cash	-	-	-	-	-	10.39
Other Current Assets	36,032	11,673	8,742	7,057	6,366	6,356
Total Current Assets	209,829	201,707	185,846	178,568	152,259	143,879
Property, Plant & Equipment	32,447	32,411	25,907	25,043	21,698	20,398
Long-Term Investments	6,437	7,186	6,143	6,878	6,622	6,388
Goodwill	24,354	24,342	22,369	21,454	20,409	20,287
Other Intangible Assets	11,050	8,229	6,948	6,536	6,359	6,149
Long-Term Deferred Tax Assets	2,539	2,375	1,969	1,773	1,435	1,067
Long-Term Deferred Charges	-	2,973	1,560	1,481	1,206	1,184
Other Long-Term Assets	7,659	6,588	7,018	5,037	5,546	3,146
Total Assets	294,316	285,811	257,760	246,770	215,534	202,497

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	87,653	64,787	58,786	54,451	48,853	42,673
Accrued Expenses	701.69	5,311	4,734	4,221	5,360	4,226
Short-Term Debt	-	363.72	-	-	10,167	10,018
Current Portion of Long-Term Debt	54,185	49,836	44,853	45,760	35,941	38,259
Current Portion of Leases	386.16	492.94	520.27	463.53	495.95	475.61
Current Income Taxes Payable	-	917.9	954.9	730.03	667.3	728.63
Current Unearned Revenue	3,196	4,142	4,225	4,023	3,538	2,898
Other Current Liabilities	838.35	16,359	18,149	24,585	16,747	15,854
Total Current Liabilities	146,960	142,209	132,222	134,233	121,770	115,132
Long-Term Debt	23,186	21,347	22,864	15,092	9,042	5,850
Long-Term Leases	731.58	730.03	768.14	844.89	770.27	759.16
Long-Term Unearned Revenue	-	781.4	713.72	788.58	775.14	725.69
Pension & Post-Retirement Benefits	733.55	744.51	773.54	761.7	828.95	886.72
Long-Term Deferred Tax Liabilities	2,175	2,131	1,915	1,718	1,587	1,601
Other Long-Term Liabilities	1,207	412.36	416.48	356.96	203.29	161.17
Total Liabilities	174,992	168,355	159,673	153,795	134,977	125,116

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	24,630	24,630	24,630	24,630	24,630	22,193
Retained Earnings	-	34,837	31,567	29,705	26,731	23,134
Comprehensive Income & Other	28,166	-8,059	-7,953	-8,376	-7,804	-3,794
Total Common Equity	52,796	51,408	48,244	45,960	43,557	41,533
Minority Interest	66,527	66,047	49,843	47,015	37,000	35,848
Shareholders' Equity	119,324	117,456	98,087	92,975	80,557	77,381
Total Liabilities & Equity	294,316	285,811	257,760	246,770	215,534	202,497

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	78,488	72,770	69,005	62,161	56,416	55,362
Net Cash (Debt)	-62,866	-44,857	-43,357	-29,930	-33,685	-31,328
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-10.03	-7.14	-6.90	-4.76	-5.36	-4.99
Filing Date Shares Outstanding	-	6,283	6,283	6,283	6,283	6,283
Total Common Shares Outstanding	-	6,283	6,283	6,283	6,283	6,283
Working Capital	62,869	59,498	53,624	44,335	30,489	28,747
Book Value Per Share	-	8.18	7.68	7.32	6.93	6.61
Tangible Book Value	17,392	18,837	18,928	17,969	16,789	15,098
Tangible Book Value Per Share	-	3.00	3.01	2.86	2.67	2.40
Buildings	-	20,694	17,264	16,124	13,507	12,991
Machinery	-	15,834	13,557	12,511	10,556	9,366
Construction In Progress	-	2,521	1,505	1,339	1,930	972.25
Leasehold Improvements	-	1,296	1,059	960.31	741.77	660.19

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error